Allergan Drug Buyers Take One Last Shot At Class Cert.
By Anne Cullen · April 23, 2019, 7:43 PM EDT
Purchasers of Allergan's ulcerative colitis drug lodged a last-ditch effort for class certification in their antitrust suit, asking a Massachusetts federal judge Monday to reconsider denying them a chance to rework...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login